New Key Statistics Module, Z-Score and F-Score
NAS:AKBA Key Ratios
Market Cap $ M | 319.64 |
Enterprise Value $ M | 333.85 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 1.71 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 174.00 |
EPS (TTM) $ | -0.21 |
Beneish M-Score | -2.15 |
10-y EBITDA Growth Rate % | 21.40 |
5-y EBITDA Growth Rate % | 55.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.13 |
EV-to-EBITDA | 72.12 |
PEG | -- |
Shares Outstanding M | 210.29 |
Net Margin (%) | -23.18 |
Operating Margin % | -20.11 |
Pre-tax Margin (%) | -23.18 |
Quick Ratio | 0.82 |
Current Ratio | 1.04 |
ROA % (ttm) | -17.19 |
ROE % (ttm) | -- |
ROIC % (ttm) | -19.37 |
Dividend Yield % | -- |
Altman Z-Score | -9.31 |
AKBA Number of Guru Trades
AKBA Volume of Guru Trades
Gurus Latest Trades with NAS:AKBA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AKBA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Akebia Therapeutics Inc Insider Transactions
No Available Data
News about NAS:AKBA
Total 0- 1